Cambridge-based Moderna played a crucial role in that ... The belt-tightening has stalled leasing of lab space in biotech centers from Kendall Square to Boston’s Seaport District, where the ...

A scientist studying a petri dish with magnifying glass in a laboratory setting. Analyst Upside: 27.83% Moderna, Inc. (NASDAQ:MRNA) is a biotech company that develops vaccines based on messenger ...

Moderna convinced a U.S. appeals court on Wednesday to uphold a ruling that undercut patent infringement claims by biotech ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

A scientist surrounded by vials and beakers in a modern laboratory, proudly displaying a vaccine. Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company focused on the discovery, development ...

based biotech company Moderna is opening an office in Seattle ... Novo Nordisk last week announced it was shutting down a lab in Seattle and laying off 86 workers, but will continue to have ...

Want to stay on top of the science and politics driving biotech today ... nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine, according to ...

After 14 years on the board of Moderna, the biotech that became a household name ... within Flagship’s innovation branch, Flagship Labs, before launching in 2010. Langer is one of nine Institute ...

But many biotech companies, like Cambridge’s Moderna, were busier than ever, and growing fast. Life-science companies, and the lab buildings that house them, looked like a sure bet for investors.

New biotech labs still need new equipment to make tomorrow ... and keep an eye out for these undervalued biotech picks. Moderna (MRNA) Moderna (NASDAQ:MRNA), once a star during the COVID-19 ...

Moderna is once again expanding its cost ... Boston Children’s pauses move into Fenway lab building New Cambridge biotech wants to stop disease before it starts New Cambridge biotech wants ...